Adage Capital Partners GP »

Crescent Biopharma shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.4M 200k 11.89
2025-06-30 $1.6M 101k 16.14

More positions owned by Adage Capital Partners GP

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
ConocoPhillips (COP)
Visa Com Cl A (V)

View all positions for Adage Capital Partners GP

Top funds holding Crescent Biopharma

FMR
Fairmount Funds Management
VR Adviser
BVF
Tang Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Driehaus Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Crescent Biopharma